<DOC>
	<DOCNO>NCT02435693</DOCNO>
	<brief_summary>Evaluation Pharmaceutical Care Program Type 2 diabetes mellitus Dhule Objectives : - 1 . To evaluate Pharmaceutical care program Type2 diabetic . 2 . To evaluate impact Pharmaceutical care quality life ( QOL ) patient Type-2 Diabetes Mellitus . 3 . To study prevalence Type2 diabetic case Dhule . 4 . To study Assessment different type adverse drug reaction ( ADRs ) . In Type2 diabetic . 5 . To evaluate Drug Drug intereaction Type-2 Diabetes Mellitus . 6 . To study impact Pharmaceutical care program glycemic control patient Type-2 Diabetes Mellitus . 7 . To study Drug utilization pattern Type-2 Diabetes Mellitus civil hospital Dhule . 8 . To compare efficiency Pharmaceutical care program drug patient Type-2 Diabetes Mellitus . 9 . To study Pharmaco-economic evaluation Type-2 Diabetes Mellitus patient 's . 10 . To increase patient compliance positive attitude patient towards diabetes disease counseling .</brief_summary>
	<brief_title>Pharmaceutical Care Program Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>To evaluate impact Pharmaceutical care quality life ( QOL ) patient Type-2 Diabetes Mellitus . To study prevalence Type2 diabetic case Dhule . To study Assessment different type adverse drug reaction ( ADRs ) . In Type2 diabetic . To evaluate Drug Drug intereaction Type-2 Diabetes Mellitus .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Patients type 2 diabetes mellitus either Patients HbA1c 7 % Patients blood sugar level 140 mg / dl Patient end stage kidney disease . Patient heart failure . Patient chronic Diabetes problem orthopedic problem</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>pharmaceutical care</keyword>
</DOC>